Filter by Interests
Looking to a future of multiplex cell engineering
Marco Alessandrini
11 January 2024
Interview
Exploring the burgeoning role of non-viral approaches in the delivery of nucleic acids
Zhenghong Gao
05 January 2024
Interview
Biological & operational considerations for iPSC-derived cell production
A Mogen, A Fernandez-Perez, J Wang et al
20 December 2023
Expert Roundtable
Building rings with spheres: a cell therapy approach to incontinence
M Gilbert, S Čaputová, D Poli et al
07 December 2023
Commentary
Efficient reprogramming of fibroblasts into iPSCs using mRNA technology
Sebastian Diecke, Hannah Johannsen, Parivash Nouri
05 December 2023
Watch
An update on prime editing: recent advances and applications
Karl Petri, Julian Grünewald
23 November 2023
Commentary
Pioneering the development of point-of-care CAR T cell therapy manufacturing in Canada: experience from the CLIC-01 CD19 CAR T clinical trial
Natasha Kekre
14 November 2023
Watch
HEK293 suspension culture in stirred 3D-systems for gene therapy development
Jorge Escobar
14 November 2023
FastFacts
Advancing multiplex base editing into the clinic
Gopi Shanker
10 November 2023
Interview
Unravelling immunogenicity induced by Cas9 in gene therapy: a comprehensive commentary of current understanding and implications
Anna Lina Cavallo
08 November 2023
Commentary
Exploring the convergence of gene editing and RNAi in iPSC-derived allogeneic cell therapy
Vlad Seitan
08 November 2023
Interview
Developing a multiplex gene editing approach targeting viral infection
TJ Cradick
08 November 2023
Interview
‘Soft’ genome editing using CRISPR nickases as a potential source of safer cell products
Zhen Li, Manuel Goncalves
20 October 2023
Expert Insight
Bringing the Sleeping Beauty transposon system to the clinic
Zoltán Ivics
18 October 2023
Interview
Cell sorting for enrichment of neuronal subpopulations – new perspectives for clinical research
Thomas Andreska, Elisa Nent, Chengjun Jin
05 October 2023
Watch
How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs
Harriet Gray Stephens
29 September 2023
Viewpoint
Utilizing an automation-on-demand analytical tool for cancer immunotherapy
Christoph Eberle
22 September 2023
Innovator Insight
Harnessing chimeric antigen receptor (CAR)-T cells as a potential treatment for Alzheimer’s disease
Lauren Sarko, Krishanu Saha
14 September 2023
Expert Insight
How patient focus drives clinical trial results: the intersection of sponsor, CRO, site, and patient
K Kane, K Nealon, B Bratrude et al
07 September 2023
Watch
Expand your T cell manufacturing capacities in an automated, closed system to shorten your production time
Sophia Lollies, Ian Johnston
31 August 2023
Watch
iNKT cells for allogeneic cell therapy
Eleni Chantzoura, Paul Ibbett
31 August 2023
Viewpoint